Press

Last day of trading in paid subscribed shares (Sw. BTA)

 

Last day of trading in subscribed paid shares ("BTA") in Acarix AB ("Acarix" or the “Company") will
be Thursday the 1 October 2020 and stop day will be Monday the 5 October 2020.
In the rights issue, which was completed on 8 September 2020, the Company issued 86,156,738 shares.
Through the rights issue, Acarix raises approx. SEK 56 million before deduction of costs related to the
rights issue.

Acarix_LAST_DAY_OF_TRADING_BTA

Acarix_SISTA_DAG_FÖR_HANDEL_BTA

 

 

 

About Acarix
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based rule out of Coronary Artery Disease (CAD). The CE approved and FDA DeNovo cleared Acarix CADScor®System is intended for patients experiencing chest pain with suspected CAD and designed to help reduce millions of unnecessary, invasive and costly diagnostic procedures. The CADScor system calculates a patient-specific CAD-score non-invasively in less than10 minutes and can help rule out more than one third of patients with at least 96% certainty of not being sick (in a population with approx. 10% CAD prevalence). Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX). Redeye AB (+46 (0)8 121 576 90, certifiedadviser@redeye.se) is Certified Advisor of Acarix.

For more information, please visit www.acarix.com.